After adjusting for differences such as age, sex, ethnicity, body mass index and other illnesses, they found that people on GLP-1 drugs had a 37 per cent higher risk of alopecia than those taking SGLT-2 inhibitors and a 68 per cent higher risk than those on DPP-4 inhibitors
In fact, the appetite-reducing effects that cause nausea are part of how the medication works
It reduces hunger, slows digestion, and helps people feel fuller for longer periods
Notably, mutations and defects in SOD1 have been associated with oxidative stress, neuroinflammation and mitochondrial dysfunction
If the predicted growth of GLP-1 users holds true, even a single percentage point increase in produce consumption translates to billions of additional dollars flowing into the industry